LUPIN
Back to Balance Sheet
|
LUPIN Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹2,390 Cr | ₹820 Cr | ₹992 Cr | ₹1,153 Cr | ₹1,136 Cr |
What is the latest Total Non-Current Liabilities ratio of LUPIN ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹2,390 Cr |
Mar2024 | ₹820 Cr |
Mar2023 | ₹992 Cr |
Mar2022 | ₹1,153 Cr |
Mar2021 | ₹1,136 Cr |
How is Total Non-Current Liabilities of LUPIN Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹2,390 Cr | 191.57 | |
Mar2024 | ₹820 Cr | -17.38 | |
Mar2023 | ₹992 Cr | -13.96 | |
Mar2022 | ₹1,153 Cr | 1.50 | |
Mar2021 | ₹1,136 Cr | - |
Compare Total Non-Current Liabilities of peers of LUPIN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LUPIN | ₹90,081.0 Cr | 2.7% | 1% | -9.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,063.0 Cr | 3% | 3.5% | -15.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,749.0 Cr | 3.1% | -4.8% | 4.9% | Stock Analytics | |
CIPLA | ₹122,429.0 Cr | 1.1% | -4% | -8.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,928.0 Cr | -1.4% | -2.6% | 4.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,168.0 Cr | -0.4% | -1.1% | -7.8% | Stock Analytics |
LUPIN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LUPIN | 2.7% |
1% |
-9.5% |
SENSEX | 0.1% |
1.3% |
-5.1% |
You may also like the below Video Courses